Related Experiment Video
Updated: Jul 1, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
No correlation between lipoprotein(a) and biochemical markers of renal function in the general population
Giuseppe Lippi1, Gian Luca Salvagno, Martina Montagnana
1Dipartimento di Scienze Morfologico-Biomediche, Università di Verona, Verona, Italy. ulippi@tin.it
Insights
Lipoprotein(a) (Lp(a)) levels are not significantly associated with kidney function markers like creatinine, estimated glomerular filtration rate (eGFR), and cystatin C in adults. Testing renal function may not improve the clinical utility of Lp(a) assessment.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Clinical Biochemistry
Background:
- Lipoprotein(a) (Lp(a)) is a recognized independent risk factor for cardiovascular disease.
- Existing research on Lp(a) in impaired renal function is conflicting.
- Limited data exists on Lp(a) association with estimated glomerular filtration rate (eGFR) and cystatin C.
Purpose of the Study:
- To investigate the relationship between Lp(a) and renal function markers (creatinine, eGFR, cystatin C).
- To assess the clinical utility of renal function tests in interpreting Lp(a) levels.
Main Methods:
- Retrospective analysis of laboratory data from 150 adult outpatients.
- Inclusion of Lp(a), creatinine, and cystatin C test results.
- Stratification of Lp(a) by renal function marker thresholds.
Main Results:
- No significant differences in Lp(a) concentrations were found based on abnormal creatinine, eGFR, or cystatin C levels.
- Prevalence of high Lp(a) (≥300 mg/L) did not differ between groups with and without impaired renal function markers.
- Multivariable analysis showed no significant association between tested renal parameters and Lp(a).
Conclusions:
- Measurement of renal function markers may offer limited clinical benefit for Lp(a) testing, unless renal function is severely compromised.
- Lp(a) assessment may be clinically useful independently of routine renal function tests.
Context:
Lipoprotein(a) (Lp(a)) is receiving major emphasis as an independent risk factor for cardiovascular disease. Results of studies on Lp(a) in patients with impaired renal function are contradictory, and no information is available on the association between Lp(a) and estimated glomerular filtration rate and cystatin C.
Objective:
To evaluate the potential relationships among the biochemical markers creatinine, estimated glomerular filtration rate, and cystatin C and their association with Lp(a) in patients with impaired renal function.
Design:
We performed a retrospective analysis using the database of our laboratory to retrieve results of Lp(a), creatinine, and cystatin C tests performed on consecutive outpatients referred by general practitioners for routine blood testing during the last year.
Results:
Cumulative results for all of the above-mentioned variables were retrieved for 150 adults older than 35 years. After stratifying Lp(a) values according to thresholds of creatinine, estimated glomerular filtration rate, and cystatin C, no significant differences in Lp(a) concentration were observed in subjects with abnormal values of these biochemical markers. The prevalence of Lp(a) values greater than or equal to 300 mg/L was not significantly different in subjects with biochemical markers suggestive of impaired renal function, as compared with those without such markers. In multivariable linear regression analysis, none of the parameters tested was significantly associated with Lp(a).
Conclusions:
We suggest that unless renal function is completely compromised, measurement of biochemical markers of renal function might be relatively unimportant to improve clinical usefulness of Lp(a) testing.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test